Plus Therapeutics, Inc. was notified by Nasdaq that it failed to meet the minimum stockholders equity requirement of $2.5 million, risking delisting unless compliance is demonstrated by March 4, 2025.
AI Assistant
PLUS THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.